Twin Focus Capital Partners »

ImmunoGen shares owned by Twin Focus Capital Partners

Quarter-by-quarter ownership of ImmunoGen shares owned by Twin Focus Capital Partners from 13F filings

Historical chart of Twin Focus Capital Partners investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Twin Focus Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Twin Focus Capital Partners

Quarter filed Position value Share count Share price at filing
2013-03-31 $3.2M 200k 16.07
2012-12-31 $3.2M 249k 12.75

More positions owned by Twin Focus Capital Partners

Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Dell Technologies CL C (DELL)
Ishares Gold Tr Ishares New (IAU)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Rus 1000 Etf (IWB)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Core Msci Emkt (IEMG)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Twin Focus Capital Partners

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen